Clinical Trial

Perioperative Lidocaine and Ketamine in Abdominal Surgery

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 21, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators propose to test the hypothesis that perioperative infusions of lidocaine and/or ketamine reduce opioid consumption and pain scores in adults recovering from elective inpatient abdominal surgery.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2019-09-09; most recent amendment 2025-05-20.
Status change: Recruiting → Active, Not Recruiting 2024-06-05
Trial Details
NCT Number NCT04084548
Lead Sponsor The Cleveland Clinic
Conditions Postoperative Pain
Enrollment 420 participants
Start Date 2019-10-15
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-21